ClinicalTrials.Veeva

Menu

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Cancer of Unknown Primary Site

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04952103
Fudan-CUP-003

Details and patient eligibility

About

This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Had a diagnosis of cancer of unknown primary (CUP) after a standard evaluation .
  • Prepared to receive first-line therapy for CUP

Exclusion criteria

  • Patients who had previously received systemic therapy for CUP
  • Previous history of other cancers, except cervix cancer or basal cell carcinoma of the skin that has been cured
  • The investigator considered that there were contraindications to treatment or were not appropriate to participate in this study

Trial contacts and locations

1

Loading...

Central trial contact

Xin Liu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems